Cosmo Energy's anti-Murakami poison pill won't improve value

Dubious shareholder vote at Japanese refinery operator only raises more questions

Avatar

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.